Why should you attend?

The premier event for top executives on Aspetic Processing | Gene & Cell Therapies

Key Learning Points

GCT Track

Navigating Regulatory Requirements: Key Considerations in Bringing Gene Therapies to Market
Optimizing Vector Serotypes for Durable Gene Expression
Strategic Vector Design and Development for Effective Gene and Cell Therapies
Investor Perspectives on Gene Therapy Development: Insights and Strategies
Reducing Timelines in Cell and Gene Therapy Drug Development: Success Stories and Challenges
CMC Strategies Tailored for Rare Diseases in Gene and Cell Therapies
Novel Approaches to Qualifying Starting and Intermediary Materials in CGT Processing
Strategies for Accelerating CGT Process Development from Preclinical to Commercialization
Controlling Immunogenicity: Developing Novel Vectors for Safer Gene Therapies
Pediatric Gene Therapy: Nuclease-Free Genomic Editing and Development Challenges

APT Track

The Evolution of Aseptic Technologies
Cleanrooms for Annex 1 Updates: Implementation Challenges and Best Practices
Innovative Approaches in Quality Risk Management for Aseptic Processes
Navigating Antibody Drug Conjugates (ADCs) and Highly Potent APIs (HPAPIs) Production
Advancements in Lyophilization for Highly Potent Products and Aseptic Processing
Occupational Safety Requirements in Aseptic Environments
Overcoming Technical Challenges in Decontamination Processes for Enhanced Safety
Robotic Applications in Aseptic Processing: Current Status and Future Trends
Single-Use Systems Implementation in Aseptic Environments
Enhancing Filtration: Strategies for Effective Filter Integrity Testing in Aseptic Operations

Who should attend?

Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments from pharmaceutical/biotechnology industry / industries involved in:

Adenovirus
Advanced Therapy Medicinal Product
Analytics
Bioprocess Research
Bioprocessing
Biotechnology
Biotherapeutics
Cell Engineering
Cell Therapy
Cell-Based Medicinal Products
Cellular Immunotherapy
Cellular Therapy
CMC
CAR-T
Clinical Development
Commercialisation
Comparability
Compliance
Container Development
Drug Development
Engineering
Fill and Finish

Formulation
Freeze-Drying
Gene Therapy
GMP
Immuno-Oncology
Immunology
Immunotherapy
Lentivirus
Licensing
Lyophilisation
Manufacturing
Market Access
Medical Affairs
Medical Devices
Nanomaterials
Non-Viral Vectors
Oncology
Packaging and Labelling
Parenterals
Pharmaceutical Process and Technology
Process Analytics
Process Development

Process Monitoring and Control
Product Characterisation
Product Innovation
Production Engineering
QA/QC
Quality Assurance
Quality Control
R&D
Regenerative Medicine
Regulatory Affairs
Research and Development
Risk Management
Safety
Scale Up
Stability
Standardisation Science
Stem Cell
Sterilization
Supply Chain
Vaccine/Antibody/Cell Manufacturing
Validation
Viral Vector

What can you expect?

➜ 100+ industry delegates

➜ 60%+ C-suite executives & SP-VP

➜ 10+ Exhibitors & Sponsors

➜ Experts on APT | GCT | CMC | Bioprocessing and many more…

➜ 5+ hours of networking events

➜ Exclusive innovative data

➜ Delegates contact information

Our Clients

Several major clients have trusted on us making BPS one of the best conferences for executives in the World.